Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

July 1, 2023; Volume 64,Issue 7

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine July 1, 2023, 64 (7) 6A;

Editor's Page

  • You have access
    JNM Editors’ Choice Awards for 2022
    Johannes Czernin
    Journal of Nuclear Medicine July 1, 2023, 64 (7) 997; DOI: https://doi.org/10.2967/jnumed.123.266027

Discussions with Leaders

  • You have access
    Leading the European Society of Cardiology
    Franz Weidinger, Frank Bengel and Johannes Czernin
    Journal of Nuclear Medicine July 1, 2023, 64 (7) 998-1000; DOI: https://doi.org/10.2967/jnumed.123.266017

State of the Art

  • You have access
    Fibroblast Activation Protein Inhibitor–Based Radionuclide Therapies: Current Status and Future Directions
    Manish Ora, Neetu Soni, Aftab Hasan Nazar, Manish Dixit, Rohit Singh, Savita Puri, Michael M. Graham and Sanjay Gambhir
    Journal of Nuclear Medicine July 1, 2023, 64 (7) 1001-1008; DOI: https://doi.org/10.2967/jnumed.123.265594

Continuing Education

  • Open Access
    Theranostics in Hematooncology
    Andreas K. Buck, Sebastian E. Serfling, Sabrina Kraus, Samuel Samnick, Niklas Dreher, Takahiro Higuchi, Leo Rasche, Hermann Einsele and Rudolf A. Werner
    Journal of Nuclear Medicine July 1, 2023, 64 (7) 1009-1016; DOI: https://doi.org/10.2967/jnumed.122.265199

Oncology

  • Basic

    • Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PET
      You have access
      Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PET
      Stanley Fayn, A. Paden King, Nicholas T. Gutsche, Zhijian Duan, Jesse Buffington, Colleen P. Olkowski, Ying Fu, Jessica Hong, Deepak Sail, Kwamena E. Baidoo, Rolf E. Swenson, Ross W. Cheloha, Mitchell Ho, Peter L. Choyke and Freddy E. Escorcia
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1017-1023; DOI: https://doi.org/10.2967/jnumed.122.265171

Theranostics

  • Clinical

    • FEATURED ARTICLE OF THE MONTH

      • PSMA PET Tumor–to–Salivary Gland Ratio to Predict Response to [<sup>177</sup>Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study
        You have access
        PSMA PET Tumor–to–Salivary Gland Ratio to Predict Response to [177Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study
        Masatoshi Hotta, Andrei Gafita, Vishnu Murthy, Matthias R. Benz, Ida Sonni, Irene A. Burger, Matthias Eiber, Louise Emmett, Andrea Farolfi, Wolfgang P. Fendler, Manuel M. Weber, Michael S. Hofman, Thomas A. Hope, Clemens Kratochwil, Johannes Czernin and Jeremie Calais
        Journal of Nuclear Medicine July 1, 2023, 64 (7) 1024-1029; DOI: https://doi.org/10.2967/jnumed.122.265242
    • Staging Prostate Cancer with <sup>68</sup>Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative?
      Open Access
      Staging Prostate Cancer with 68Ga-PSMA-11 PET/CT in the Elderly: Is Preimaging Biopsy Imperative?
      Mikhail Kesler, Dan Cohen, Charles Levine, David Sarid, Daniel Keizman, Ofer Yossepowitch and Einat Even-Sapir
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1030-1035; DOI: https://doi.org/10.2967/jnumed.122.265371
    • Delayed Imaging Improves Lesion Detectability in [<sup>99m</sup>Tc]Tc-PSMA-I&amp;S SPECT/CT in Recurrent Prostate Cancer
      You have access
      Delayed Imaging Improves Lesion Detectability in [99mTc]Tc-PSMA-I&S SPECT/CT in Recurrent Prostate Cancer
      Christoph Berliner, Lisa Steinhelfer, Maythinee Chantadisai, Markus Kroenke, Daniel Koehler, Randi Pose, Peter Bannas, Sophie Knipper, Matthias Eiber and Tobias Maurer
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1036-1042; DOI: https://doi.org/10.2967/jnumed.122.265252
    • <sup>68</sup>Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study
      You have access
      68Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study
      Riccardo Mei, Lukas Kessler, Kim M. Pabst, Manuel Weber, Christian Schmidkonz, Christoph Rischpler, Helle Damgaard Zacho, Thomas Hope, Sarah M. Schwarzenböck, Martin Allen-Auerbach, Louise Emmett, Justin Ferdinandus, Marcus Unterrainer, Benedikt M. Schaarschmidt, Lale Umutlu, Andrea Farolfi, Paolo Castellucci, Cristina Nanni, Silvi Telo, Stefano Fanti, Ken Herrmann and Wolfgang P. Fendler
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1043-1048; DOI: https://doi.org/10.2967/jnumed.122.265245
    • Superior Tumor Detection for <sup>68</sup>Ga-FAPI-46 Versus <sup>18</sup>F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma
      Open Access
      Superior Tumor Detection for 68Ga-FAPI-46 Versus 18F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma
      Kim M. Pabst, Marija Trajkovic-Arsic, Phyllis F.Y. Cheung, Simone Ballke, Katja Steiger, Timo Bartel, Benedikt M. Schaarschmidt, Aleksandar Milosevic, Robert Seifert, Michael Nader, Lukas Kessler, Jens T. Siveke, Katharina Lueckerath, Stefan Kasper, Ken Herrmann, Nader Hirmas, Hartmut H. Schmidt, Rainer Hamacher and Wolfgang P. Fendler
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1049-1055; DOI: https://doi.org/10.2967/jnumed.122.265215
  • Basic

    • FEATURED BASIC SCIENCE ARTICLE

      • Addition of Peptide Receptor Radiotherapy to Immune Checkpoint Inhibition Therapy Improves Outcomes in Neuroendocrine Tumors
        You have access
        Addition of Peptide Receptor Radiotherapy to Immune Checkpoint Inhibition Therapy Improves Outcomes in Neuroendocrine Tumors
        Shadi A. Esfahani, Carolina De Aguiar Ferreira, Priska Summer, Umar Mahmood and Pedram Heidari
        Journal of Nuclear Medicine July 1, 2023, 64 (7) 1056-1061; DOI: https://doi.org/10.2967/jnumed.123.265391
    • Evaluation of Candidate Theranostics for <sup>227</sup>Th/<sup>89</sup>Zr Paired Radioimmunotherapy of Lymphoma
      Open Access
      Evaluation of Candidate Theranostics for 227Th/89Zr Paired Radioimmunotherapy of Lymphoma
      Diane S. Abou, Mark Longtine, Amanda Fears, Nadia Benabdallah, Ryan Unnerstall, Hannah Johnston, Kyuhwan Shim, Abbie Hasson, Hanwen Zhang, David Ulmert, Floriane Mangin, Serife Ozen, Laurent Raibaut, Stéphane Brandès, Michel Meyer, Jean-Claude Chambron, David S. Tatum, Darren Magda, Richard L. Wahl and Daniel L.J. Thorek
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1062-1068; DOI: https://doi.org/10.2967/jnumed.122.264979
    • PSMA-GCK01: A Generator-Based <sup>99m</sup>Tc/<sup>188</sup>Re Theranostic Ligand for the Prostate-Specific Membrane Antigen
      Open Access
      PSMA-GCK01: A Generator-Based 99mTc/188Re Theranostic Ligand for the Prostate-Specific Membrane Antigen
      Jens Cardinale, Frederik L. Giesel, Christina Wensky, Hendrik G. Rathke, Uwe Haberkorn and Clemens Kratochwil
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1069-1075; DOI: https://doi.org/10.2967/jnumed.122.264944
    • Evaluation of <sup>134</sup>Ce/<sup>134</sup>La as a PET Imaging Theranostic Pair for <sup>225</sup>Ac α-Radiotherapeutics
      Open Access
      Evaluation of 134Ce/134La as a PET Imaging Theranostic Pair for 225Ac α-Radiotherapeutics
      Kondapa Naidu Bobba, Anil P. Bidkar, Niranjan Meher, Cyril Fong, Anju Wadhwa, Suchi Dhrona, Alex Sorlin, Scott Bidlingmaier, Becka Shuere, Jiang He, David M. Wilson, Bin Liu, Youngho Seo, Henry F. VanBrocklin and Robert R. Flavell
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1076-1082; DOI: https://doi.org/10.2967/jnumed.122.265355

Cardiovascular

  • Clinical

    • BRIEF COMMUNICATION

      • Regression of Myocardial <sup>99m</sup>Tc-DPD Uptake After Tafamidis Treatment of Cardiac Transthyretin Amyloidosis
        You have access
        Regression of Myocardial 99mTc-DPD Uptake After Tafamidis Treatment of Cardiac Transthyretin Amyloidosis
        Maria Papathanasiou, Lukas Kessler, Frank M. Bengel, Aiste-Monika Jakstaite, David Kersting, Zohreh Varasteh, Peter Luedike, Alexander Carpinteiro, Ken Herrmann, Tienush Rassaf and Christoph Rischpler
        Journal of Nuclear Medicine July 1, 2023, 64 (7) 1083-1086; DOI: https://doi.org/10.2967/jnumed.122.265352

Neurology

  • Clinical

    • Hybrid <sup>18</sup>F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases
      Open Access
      Hybrid 18F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases
      Nathaniel J. Smith, Tristan K. Deaton, Wendy Territo, Brian Graner, Andrew Gauger, Scott E. Snyder, Michael L. Schulte, Mark A. Green, Gary D. Hutchins and Michael C. Veronesi
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1087-1092; DOI: https://doi.org/10.2967/jnumed.122.265149
    • INVITED PERSPECTIVE

      • You have access
        Hybrid 18F-FET PET and Perfusion MRI to Differentiate Disease Progression from Treatment-Related Changes in Malignant Brain Tumors
        Norbert Galldiks and Karl-Josef Langen
        Journal of Nuclear Medicine July 1, 2023, 64 (7) 1093-1094; DOI: https://doi.org/10.2967/jnumed.123.265647

Radiobiology/Dosimetry

  • Clinical

    • Multicenter Evaluation of Frequency and Impact of Activity Infiltration in PET Imaging, Including Microscale Modeling of Skin-Absorbed Dose
      Open Access
      Multicenter Evaluation of Frequency and Impact of Activity Infiltration in PET Imaging, Including Microscale Modeling of Skin-Absorbed Dose
      John J. Sunderland, Stephen A. Graves, Dusty M. York, Christine A. Mundt and Twyla B. Bartel
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1095-1101; DOI: https://doi.org/10.2967/jnumed.123.265891
    • Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with <sup>90</sup>Y Glass Microspheres
      You have access
      Voxel-Based Dosimetry Predicts Hepatotoxicity in Hepatocellular Carcinoma Patients Undergoing Radioembolization with 90Y Glass Microspheres
      Masao Watanabe, Hong Grafe, Jens Theysohn, Benedikt Schaarschmidt, Johannes Ludwig, Leonie Jochheim, Matthias Jeschke, Hartmut Schmidt, Wolfgang P. Fendler, Alexandros Moraitis, Ken Herrmann, Kelsey L. Pomykala and Manuel Weber
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1102-1108; DOI: https://doi.org/10.2967/jnumed.122.264996
    • An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 2: Overall Variabilities in Absorbed Dose
      Open Access
      An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 2: Overall Variabilities in Absorbed Dose
      Julia Brosch-Lenz, Suqi Ke, Hao Wang, Eric Frey, Yuni K. Dewaraja, John Sunderland and Carlos Uribe
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1109-1116; DOI: https://doi.org/10.2967/jnumed.122.265094
    • SPECIAL CONTRIBUTION

      • You have access
        MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
        Adam L. Kesner, Lukas M. Carter, Juan C. Ocampo Ramos, Daniel Lafontaine, Edmond A. Olguin, Justin L. Brown, Bonnie President, Derek W. Jokisch, Darrell R. Fisher and Wesley E. Bolch
        Journal of Nuclear Medicine July 1, 2023, 64 (7) 1117-1124; DOI: https://doi.org/10.2967/jnumed.122.264225
    • The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer
      Open Access
      The Role of Pretherapy Quantitative Imaging and Dosimetry in Radioiodine Therapy for Advanced Thyroid Cancer
      Jan Taprogge, Carla Abreu, Siraj Yusuf, Gemma Ainsworth, Rachel H. Phillip, Jonathan I. Gear, Rebecca Gregory, Francesca Leek, Iain Murray, Amy B. Coulson, Sarah R. Brown, Yong Du, Kate Newbold, Jonathan Wadsley and Glenn D. Flux
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1125-1130; DOI: https://doi.org/10.2967/jnumed.122.264913
    • Optimized SPECT Imaging of <sup>224</sup>Ra α-Particle Therapy by <sup>212</sup>Pb Photon Emissions
      Open Access
      Optimized SPECT Imaging of 224Ra α-Particle Therapy by 212Pb Photon Emissions
      Lars Tore Gyland Mikalsen, Monika Kvassheim and Caroline Stokke
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1131-1137; DOI: https://doi.org/10.2967/jnumed.122.264455

Radiochemistry/Radiopharmaceuticals

  • Clinical

    • <sup>161</sup>Tb-DOTATOC Production Using a Fully Automated Disposable Cassette System: A First Step Toward the Introduction of <sup>161</sup>Tb into the Clinic
      Open Access
      161Tb-DOTATOC Production Using a Fully Automated Disposable Cassette System: A First Step Toward the Introduction of 161Tb into the Clinic
      Chiara Favaretto, Pascal V. Grundler, Zeynep Talip, Stefan Landolt, Lebogang Sepini, Ulli Köster, Cristina Müller, Roger Schibli, Susanne Geistlich and Nicholas P. van der Meulen
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1138-1144; DOI: https://doi.org/10.2967/jnumed.122.265268

AI/Advanced Image Analysis

  • Clinical

    • Fully Automated, Fast Motion Correction of Dynamic Whole-Body and Total-Body PET/CT Imaging Studies
      You have access
      Fully Automated, Fast Motion Correction of Dynamic Whole-Body and Total-Body PET/CT Imaging Studies
      Lalith Kumar Shiyam Sundar, Martin Lyngby Lassen, Sebastian Gutschmayer, Daria Ferrara, Anna Calabrò, Josef Yu, Kilian Kluge, Yiran Wang, Lorenzo Nardo, Philip Hasbak, Andreas Kjaer, Yasser G. Abdelhafez, Guobao Wang, Simon R. Cherry, Benjamin A. Spencer, Ramsey D. Badawi, Thomas Beyer and Otto Muzik
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1145-1153; DOI: https://doi.org/10.2967/jnumed.122.265362
    • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
      You have access
      High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
      Yiran Wang, Benjamin A. Spencer, Jeffrey Schmall, Elizabeth Li, Ramsey D. Badawi, Terry Jones, Simon R. Cherry and Guobao Wang
      Journal of Nuclear Medicine July 1, 2023, 64 (7) 1154-1161; DOI: https://doi.org/10.2967/jnumed.122.264810

Illustrated Post

  • You have access
    Incidental Detection of a Tenosynovial Giant Cell Tumor of the Thigh on [68Ga]Ga-FAPI PET/CT: Presentation of an Unusual Case
    Timur Sellmann, Felicitas Staak, Clemens Maurer, Gernot Rott, Oliver Witzke, Wolfgang Fendler, Hans-Ulrich Schildhaus, Lars Erik Podleska, Ken Herrmann and Christoph Rischpler
    Journal of Nuclear Medicine July 1, 2023, 64 (7) 1162-1163; DOI: https://doi.org/10.2967/jnumed.118.207761

Letters to the Editor

  • You have access
    Clinical Potential of HER2 PET as a Predictive Biomarker to Guide the Use of Trastuzumab Deruxtecan in Breast Cancer Patients
    Romain-David Seban, Laurence Champion, Audrey Bellesoeur, Anne Vincent-Salomon and Francois-Clement Bidard
    Journal of Nuclear Medicine July 1, 2023, 64 (7) 1164-1165; DOI: https://doi.org/10.2967/jnumed.123.265434
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 64 (7)
Journal of Nuclear Medicine
Vol. 64, Issue 7
July 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • PSMA PET Tumor–to–Salivary Gland Ratio to Predict Response to [177Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study
  • Addition of Peptide Receptor Radiotherapy to Immune Checkpoint Inhibition Therapy Improves Outcomes in Neuroendocrine Tumors
Sign up for alerts

Jump to

  • This Month in JNM
  • Editor's Page
  • Discussions with Leaders
  • State of the Art
  • Continuing Education
  • Oncology
    • Basic
  • Theranostics
    • Clinical
      • FEATURED ARTICLE OF THE MONTH
    • Basic
      • FEATURED BASIC SCIENCE ARTICLE
  • Cardiovascular
    • Clinical
      • BRIEF COMMUNICATION
  • Neurology
    • Clinical
      • INVITED PERSPECTIVE
  • Radiobiology/Dosimetry
    • Clinical
      • SPECIAL CONTRIBUTION
  • Radiochemistry/Radiopharmaceuticals
    • Clinical
  • AI/Advanced Image Analysis
    • Clinical
  • Illustrated Post
  • Letters to the Editor
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire